Haemoglobin and red blood cell reference intervals during infancy

Sara Marie Larsson1,2, Lena Hellström-Westas3, Andreas Hillarp4

  • 1Department of Clinical Chemistry, Halland Hospital, Halmstad/Varberg, Sweden marie.larsson@med.lu.se.

Insights

Updated infant hematology reference data is crucial. This study established new reference intervals for hemoglobin and red blood cell biomarkers in Swedish infants, revealing narrower ranges and age-dependent variations.

Area of Science:

  • Pediatrics
  • Hematology
  • Clinical Chemistry

Background:

  • Establishing accurate hematological reference data for infants is essential for diagnosing and managing various conditions.
  • Previous reference intervals may not reflect current infant populations or practices, such as delayed cord clamping.

Purpose of the Study:

  • To define updated reference intervals for hemoglobin and red blood cell biomarkers in a large cohort of longitudinally followed Swedish infants.
  • To provide age-specific reference data crucial for accurate interpretation in pediatric hematology.

Main Methods:

  • A longitudinal cohort study involving 442 healthy, term-born Swedish infants with delayed umbilical cord clamping.
  • Blood samples were collected at multiple time points: umbilical cord, 48-118 hours, 4 months, and 12 months.
  • Reference intervals were calculated as the 2.5th and 97.5th percentiles following Clinical and Laboratory Standards Institute guidelines.

Main Results:

  • Narrower reference intervals for hemoglobin and mean cell volume were observed compared to previous studies.
  • Significant age-dependent variations in reference intervals for all measured hematological parameters were identified.
  • At 12 months, 16% of the cohort met the WHO definition of anemia (hemoglobin < 110 g/L), despite favorable birth conditions.

Conclusions:

  • The study highlights the necessity of age-specific reference intervals for infant hematological parameters.
  • The established narrower reference intervals provide a more precise benchmark for clinical assessment.
  • The observed discrepancy with WHO anemia classification warrants further investigation into factors influencing infant hemoglobin levels.
Abstract

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.4K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.0K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
516
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
34
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.6K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.0K